Skandinaviska Enskilda Banken (SEB)’s Tandem Diabetes Care TNDM Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-118,221	Closed	-$4.77M	–	843
2024 Q2	$4.77M	Hold	118,221	–	–	0.02%	387
2024 Q1	$4.19M	Hold	118,221	–	–	0.02%	427
2023 Q4	$3.5M	Hold	118,221	–	–	0.02%	447
2023 Q3	$2.46M	Hold	118,221	–	–	0.02%	501
2023 Q2	$2.9M	Sell	118,221 -4,173	-3%	-$134K	0.02%	479
2023 Q1	$4.97M	Sell	122,394 -201	-0.2%	-$8.32K	0.03%	368
2022 Q4	$5.51M	Sell	122,595 -62	-0.1%	-$2.81K	0.04%	342
2022 Q3	$5.87M	Hold	122,657	–	–	0.05%	329
2022 Q2	$7.26M	Buy	122,657 +25,058	+26%	+$2.06M	0.05%	298
2022 Q1	$11.3M	Buy	97,599 +794	+0.8%	+$92.7K	0.07%	253
2021 Q4	$14.7M	Buy	96,805 +732	+0.8%	+$98.8K	0.08%	229
2021 Q3	$11.5M	Hold	96,073	–	–	0.06%	261
2021 Q2	$9.36M	Hold	96,073	–	–	0.06%	291
2021 Q1	$8.48M	Buy	+96,073	New	+$8.93M	0.06%	295

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s TNDM Position: Q3 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 118,221 shares — an estimated $4.77M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TNDM in Q1 2021 and held it in 14 quarters. The position peaked at $14.7M in Q4 2021. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

Skandinaviska Enskilda Banken (SEB) reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 118,221 Tandem Diabetes Care shares in Q3 2024, an estimated $4.77M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 14 quarters.
Skandinaviska Enskilda Banken (SEB)'s Tandem Diabetes Care position peaked at $14.7M in Q4 2021.
332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2024, filed 7 Nov 2024.